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the Perioperative Period
E. S. Xenos and D. L. Davenport, The University of Kentucky Medical
Center and The Veterans Administration Medical Center, Lexington, Ky
Background: Red blood cell (RBC) transfusion is a common event in
the perioperative course of patients undergoing surgery. Transfused blood
can disrupt the balance of coagulation factors and modulate the inflamma-
tory cascade. Since inflammation and coagulation are tightly coupled, we
postulated that RBC transfusion may be associated with the development of
venous thromboembolic phenomena. We queried the American College of
Surgeon’s National Surgical Quality Improvement Program database to
examine the relationship between intraoperative blood transfusion and
development of venous thromboembolism in patients undergoing colorectal
resection for cancer (Table).
Methods: We analyzed the data from 2005 to 2008 for patients
undergoing colorectal resections for cancer based on the primary procedure
Current Procedure Terminology-4 code and operative International Classi-
fication of Diseases-9 diagnosis code. The primary outcomewas 30-day deep
vein thrombosis (DVT) and/or pulmonary embolism (PE). Intraoperative
transfusion of RBCwas categorized as none, 1-2 units, 3-5 units, and 6 units
or more. DVT and/or PE occurrences were analyzed by multivariable
forward stepwise regression (P for entry  .05, for exit  .10) to identify
independent predictors of DVT.
Results: The database contained 21,943 colorectal cancer resections.
The DVT rate was 1.4% (306/21,943), and the PE rate was 0.8% (180/
21,943). Patients were diagnosed with both only 40 times, and the com-
bined DVT or PE rate was 2.0% (446/21,943). After adjusting for age,
gender, race, American Society of Anesthesiologists class, emergency proce-
dure, operative duration, and complexity of the procedure (based on relative
value units), along with six clinical risk factors, intraoperative blood trans-
fusion was a significant risk fact for the development of venous thromboem-
bolism as shown in the following table. Preoperative hematocrit did not
enter the multivariable model as an independent predictor of venous throm-
boembolism, nor did open versus laparoscopic resection. The risk for the
outcome increased with increasing number of units transfused.
Conclusion: In this study of 21,943 patients undergoing colorectal
resection for cancer, blood transfusion is associated with increased risk of
venous thromboembolism. This increased thrombotic risk may be related to
dilution of anticoagulant factors, viscosity changes, or immunologic effects
as well as the formation of microaggregates, which are composed of degen-
erating platelets, granulocyte debris, and fibrin strands; these form rapidly
during blood storage. Malignancy and surgery are known prothrombotic
stimuli. The subset of patients receiving intraoperative RBC transfusions is
even more at risk for venous thromboembolism, emphasizing the need for
sensible use of transfusions and rigorous thromboprophylaxis regimens.
Downregulation of Hypoxia-Inducible Factor-1 Alpha Reduces Ve-
nous Thrombus Resolution
C. E. Evans, J. Humphries, K. Mattock, M. Waltham, A. Wadoodi, P. Saha, B.
Modarai, and A. Smith, King’s College London, London, United Kingdom
Background: Hypoxia-inducible factor-1 (HIF-1)-mediated angio-
genic factors, such as vascular endothelial growth factor (VEGF), are in-
duced within venous thrombus during its resolution, but the primary
stimulus for VEGF production and thrombus resolution is unknown. Our
aim was to determine whether downregulatingHIF-1 in the thrombus and
vein wall reduces angiogenic factor expression, inflammatory cell infiltration,
and thrombus resolution.
Methods: Thrombus was induced in the inferior vena cava (IVC) of 40
mice. The mice were treated with the HIF-1 inhibitor 2-methoxyestradiol
Table.
Intraoperative transfusion
packed red blood cells
30-day venous
thromboembolism rate
M
0 units (n  19,588, 89.3%) 1.8% Re
1-2 units (n  1751, 8.0%) 3.7% 1.
3-5 units (n  466, 2.1%) 4.9% 1.
6 units (n  138, 0.6%) 9.4% 3.189(2ME; intraperitoneal, 150 mg/kg/day) or vehicle control (n  20/
group). HIF-1, VEGF, and placental growth factor (PLGF) expression in
the thrombus and IVC were measured at days 1 and 10 (n  7/group) by
enzyme-linked immunosorbent assay. Thrombus size, neovascularization,
recanalization, and macrophage and neutrophil infiltration were also mea-
sured at day 10 by image analysis (n  6/group).
Results: The levels of HIF-1 (P  .001), VEGF (P  .001), and
PLGF (P .001), and neutrophil (P .005) and macrophage (P .05, Fig
1) infiltration were decreased in the thrombus of mice treated with 2ME
compared with vehicle control. The levels of HIF-1 (P  .005), VEGF (P
 .005), and PLGF (P  .001), and neutrophil (P  .01) and macrophage
(P .005, Fig 2) infiltration were also decreased in the IVC wall surround-
ing the thrombus of 2ME-treated mice compared with controls. Thrombus
weight (P  .001, Fig 3) and size (P  .02, Fig 4) were increased, while
thrombus neovascularization (P .005, Fig 5) and vein recanalization (P
.005, Fig 6) were decreased in 2ME-treated mice compared with controls.
Conclusions: Reducing HIF-1 expression in the thrombus and vein
wall reduces angiogenic growth factor expression, inflammatory cell infiltra-
tion, and thrombus resolution. These data suggest that HIF-1 activity is an
important regulatory mechanism in thrombus resolution.
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January 2011252 AbstractsCatheter-Directed Thrombolysis of Iliofemoral Deep Vein Thrombosis
Reduces Deep Vein Thrombosis Recurrence
F. Aziz, J. T. Chen, and A. J. Comerota, The Toledo Hospital, Toledo,
Ohio
Background: Iliofemoral deep vein thrombosis (DVT) is a result of a
major thrombotic stimulus that results in substantial postthrombotic mor-
bidity in patients treated with anticoagulation alone. It has been shown that
iliofemoral DVT is a powerful and independent risk factor for recurrent
thromboembolism. Furthermore, recurrent DVT escalates postthrombotic
morbidity, since recurrent DVT has been correlated with residual venous
thrombus. Eliminating thrombus in high-risk patients might reduce the risk
of recurrence. We reviewed the entire cohort of patients with iliofemoral
DVT treated with catheter-directed thrombolysis to determine their risk of
recurrence and whether there was a relationship to lytic success.
Methods: All patients who underwent catheter-based thrombus re-
moval for iliofemoral DVT had their degree of lysis assessed by comparison
of pre- and postprocedural phlebography and were classified according to
the percentage of residual thrombus. Recurrence was defined as a symptom-
atic presentation with image verification of new or additional thrombus.
Results: Sixty-two patients underwent catheter-directed thrombolysis
for iliofemoral DVT. Mean age was 45 17 years (range, 16-79 years), and
35 patients (56%) were male. Mean follow-up was 18.9 months and seven
patients (11%) were lost to follow up. Forty-eight patients (87%) had no
recurrence, and seven patients (13%) developed recurrent DVT. Recurrence
developed in 67% of patients who had60% residual thrombus but occurred
in 10% of those who had 60% residual thrombus (P  .0253). The seven
patients who developed recurrent DVT were anticoagulated at the time of
recurrence.
Conclusion: Patients who underwent either catheter-directed throm-
bolysis of iliofemoral DVT have lower incidence of recurrent deep vein
thrombosis as compared with historic groups who are treated by anticoag-
ulation alone. Furthermore, there is a direct correlation between the amount
of residual thrombus following catheter-based thrombolysis and recurrence.
As lytic success improves, the risk of recurrent DVT decreases. These data
raise the hypothesis that successful thrombolysis reduces recurrence rates,
which requires validation in prospective studies.
Creation of a Simple Venous Thromboembolism Risk Score for Out-
patient Surgery: Analysis of the National Surgical Quality Improve-
ment Program Database
C. J. Pannucci, A. Shanks, M.Moote, V. Bahl, P. Cederna, N. Naughton, P.
Henke, S. Kheterpal, and S. Campbell, The University of Michigan, Ann
Arbor, Mich
Background:Factors that contribute to venous thromboembolism
(VTE) risk after outpatient surgery are unknown. We used the National
Surgical Quality Improvement Program (NSQIP) database to examine risk
factors for VTE after outpatient surgery and empirically derive a VTE
risk-scoring model.
Methods: The NSQIP is a prospective database of surgical patients
with 30-day outcomes. Inclusion criteria for this analysis were age 18,
surgery classified as “outpatient,” and length of stay equal to zero days.
Independent variables included known VTE risk factors (Table). Age,
operative time, and body mass index were transformed to categorical vari-
ables to facilitate risk-score creation.
Trained NSQIP clinical nurses collect risk factor and adverse event data
using medical record review. Mandatory nurse-patient contact on postoper-
ative day 30 identifies complications treated at other hospitals. The NSQIP
defines deep vein thrombosis (DVT) as venous clots requiring either sys-
temic anticoagulation or inferior vena cava filter. Pulmonary embolus is
defined as an obstructing pulmonary arterial clot. Imaging is required for
DVT or pulmonary embolism (PE) diagnosis. The primary study outcome
was VTE, generated as a composite of DVT and/or PE.
Multivariable logistic regression identified independent risk factors.
-coefficients for independent predictors were used to derive a weighted
risk-scoringmodel; this was compared to the unweighted risk-scoringmodel
using the c-statistic.
Results: For this study, 168,518 patients met the inclusion criteria.
DVT incidence was 0.1% (172 patients), PE was 0.04% (38 patients), and
VTE was 0.12% (210 patients). Of patients with VTE, 1 in 10 (0.013%
overall) had both DVT and PE.
Independent predictors of VTE included arthroscopic surgery, current
pregnancy, active cancer, and invasive venous procedure. When compared
with the reference group, age 41 to 60 years, age60 years, bodymass index
40, and operative time 120 minutes were also independent predictors
(Table). The model accounted for 80% of the variability in VTE (c-statistic
0.800). The average time-to-event for both DVT and PE was postoperative
day 10  7.
C-statistic for weighted risk scores (0.76  0.02) was significantly
higher than the unweighted risk score (0.72  0.02). The weighted risk-
score model is shown in the Fig.
